Zhang Chong, Zhang Jin, Xie Daotao, Guo Gang, Jalili Saman
Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Department of Emergency Traumatology, Gejiu People's Hospital, Yunnan, 661000, China.
Regen Ther. 2024 Oct 8;26:879-888. doi: 10.1016/j.reth.2024.09.008. eCollection 2024 Jun.
When subjected to injury, the spinal cord's inherent complexity poses significant challenges for effective healing. In this study, gelatin nanofibers loaded with Laurus nobilis extract were developed to serve as a delivery system for adipose-derived stem cells (ADSCs), aiming to explore its potential immunomodulatory effects in a rat model of spinal cord injury. Through a series of in vitro assessments including scanning electron microscopy imaging, cell viability, anti-inflammatory, cell adhesion, biodegradation, and hemocompatibility assays, the characteristics of the delivery system were thoroughly evaluated. The in vitro studies revealed both the biocompatibility of the scaffolds and their notable anti-inflammatory properties, laying the groundwork for further investigation. Subsequent in vivo experiments demonstrated that rats treated with Laurus nobilis extract and ADSCs loaded scaffolds exhibited heightened functional recovery (BBB score of 14.66 ± 1.52 % and hot plate latency time of 8.33 0.26 s) and histological restoration at the 8-week mark post-injury. Notably, ELISA assay results revealed a significant reduction in tissue expression levels of key pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, suggesting a pronounced immunomodulatory effect of the Laurus nobilis extract-loaded scaffolds. The findings underscore the potential of this novel delivery system to improve clinical outcomes in spinal cord injury by enhancing functional recovery and reducing inflammation. This approach could lead to the development of new, natural-based therapeutic strategies for spinal cord injury, with potential extensions to other inflammatory or degenerative conditions. Future research should focus on optimizing this strategy in larger animal models and eventually translating these findings into human clinical trials.
脊髓受伤时,其固有的复杂性给有效愈合带来了重大挑战。在本研究中,开发了负载月桂提取物的明胶纳米纤维,作为脂肪来源干细胞(ADSCs)的递送系统,旨在探索其在大鼠脊髓损伤模型中的潜在免疫调节作用。通过一系列体外评估,包括扫描电子显微镜成像、细胞活力、抗炎、细胞黏附、生物降解和血液相容性测定,对递送系统的特性进行了全面评估。体外研究揭示了支架的生物相容性及其显著的抗炎特性,为进一步研究奠定了基础。随后的体内实验表明,用月桂提取物和负载ADSCs的支架治疗的大鼠在损伤后8周时功能恢复增强(BBB评分为14.66±1.52%,热板潜伏期为8.33±0.26秒)且组织学得到恢复。值得注意的是,ELISA检测结果显示关键促炎细胞因子(包括TNF-α、IL-1β和IL-6)的组织表达水平显著降低,表明负载月桂提取物的支架具有明显的免疫调节作用。这些发现强调了这种新型递送系统通过增强功能恢复和减轻炎症来改善脊髓损伤临床结果的潜力。这种方法可能会导致开发新的基于天然物质的脊髓损伤治疗策略,并有可能扩展到其他炎症或退行性疾病。未来的研究应集中在大型动物模型中优化这一策略,并最终将这些发现转化为人体临床试验。